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Five cases of human babesiosis were reported in the
Lower Hudson Valley Region of New York State in 2001. An
investigation to determine if Babesia microti was present in
local Ixodes scapularis ticks yielded 5 positive pools in 123
pools tested, the first detection of B. microti from field-col-
lected I. scapularis in upstate New York.
B
abesiosis is a malarialike infection often caused in
humans by the bite of an infected tick (1,2). Currently,
most cases of human babesiosis in the United States occur
in the northeastern and northern Midwest portions of the
country and may be attributed to infection with Babesia
microti (2,3). B. microti is maintained naturally through
the same reservoir (the White-footed mouse, Peromyscus
leucopus) and vector (the Black-legged tick, Ixodes scapu-
laris) as Borrelia burgdorferi, the etiologic agent of Lyme
disease in the United States (1,4,5). 
Human cases of babesiosis caused by B. microti were
first identified in the United States in coastal areas of the
Northeast, including several islands off the coast of Cape
Cod, Massachusetts; in Rhode Island; and on Long Island,
New York (1). Studies in Connecticut, Maine, and New
Jersey have detected B. microti in other northeastern areas.
In New Jersey, human cases have been reported from var-
ious inland locations across the state (6,7). In addition, B.
microti has been identified in local populations of I. scapu-
laris from the western portion of the state (8). B. microti
has recently been found in local populations of White-foot-
ed mice collected in Connecticut (9,10). Detection of B.
microti in Maine has been reported from the Southern Red-
backed Vole (Clethrionomys gapperi), the Masked Shrew
(Sorex cinereus), and the Northern Short-tail Shrew
(Blarina brevicauda) (11), as well as from questing I.
scapularis (12). 
The first reported case of human babesiosis in New
York was from Long Island in 1975 (13). Previously,
detection of B. microti in New York has been limited to
small mammals from Shelter Island (off the eastern end of
Long Island) (13), except for 1 study in 1958 that identified
B. microti in blood smears taken from a local population of
Meadow Voles (Microtus pennsylvanicus) in the central
portion of the state, near Ithaca (14). From 1986, when
babesiosis officially became a reportable disease in New
York, to 2001, a total of 560 human cases have been report-
ed. Before 2000, most human babesiosis cases were report-
ed from residents of Long Island. Cases reported from
residents of upstate New York (north of New York City) are
limited; most patients reported travel to locations with a
known risk of potential exposure to B. microti (15). In
2001, 5 confirmed cases of human babesiosis were report-
ed from residents of the Lower Hudson Valley who lived
and worked north of recognized risk areas and for whom
acquisition of the pathogen by blood transfusion or travel
was ruled out (New York State Department of Health,
unpub. data). These presumably locally acquired human
cases were reported from 4 counties: Columbia (n = 1),
Dutchess (n = 2), Putnam (n = 1), and Westchester (n = 1)
(Figure).
The Study
In response to these presumably locally acquired
human cases, an investigation was initiated to detect B.
microti in local host-seeking populations of I. scapularis.
Using the limited epidemiologic information available, we
chose sites near the residences of suspected locally
acquired human case-patients. Typical sites included parks
and recreational areas run by state, county, or town govern-
ments. All sites were locations in which the possibility of
human exposure to potentially infected ticks was consid-
ered high. Ticks were collected for 1 hour from each site
during spring and fall of 2002 by using a combination of
standard techniques, including walking and flagging using
a 1-m2 piece of white cloth (16). All ticks encountered
were collected and kept alive until returned to the labora-
tory, where they were maintained at 4°C until they were
sorted by life stage and identified to species (17).
Specimens were stored in 80% ethanol I. scapularis were
pooled by location and life stage for testing purposes.
Pools consisted of 1 to 10 ticks and were tested for B.
microti by polymerase chain reaction (PCR) in a blinded
fashion. All samples were treated and processed alike, in
addition to undergoing the same PCR conditions and
analysis.
Briefly, each pool of ticks was homogenized with 125
µL of 5% Chelex-100 resin (BioRad, Richmond, CA,
USA) to extract the DNA(the Chelex-100 DNAextraction
procedure is the subject of a manuscript in preparation).
The primers Bab 1 (5′-CTTAGTATAAGCTTTTAT-
ACAGC-3′) and Bab 4 (5′-ATAGGTCAGAAACTTGAA-
TGATACA-3′), targeting the 16S-like small subunit gene
(3), amplified a product 238 bp in size. Each reaction
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deoxynucleoside triphosphate mixture (Roche), 5 U of Taq
DNA polymerase, and 5 µL of sample. A negative control
consisting of 5 µL of nuclease-free H2O was included with
each run (nuclease-free, reagent quality H2O was used
throughout to dilute reagents). Known negative tick con-
trols included Amblyomma americanum, which do not har-
bor  B. microti, and  I. scapularis from areas where
babesiosis is unknown. A positive control consisting of
DNA (5  µL) extracted from whole blood of a B.
microti–infected C3H/HeN mouse (PureGene DNA Blood
Isolation Kit, Gentra Systems, Minneapolis, MN, USA)
was also included. The PCR was carried out in a GeneAmp
PCR System 9700 (Applied Biosystems, Foster City, CA,
USA) under the following conditions: 5 min of initial
denaturation at 94°C, followed by 35 cycles of denatura-
tion at 94°C (20 s), annealing at 55°C (30 s), and extension
at 72°C (30 s). Electrophoresis was carried out on 2%
agarose gels, followed by staining with ethidium bromide. 
Atotal of 1,139 I. scapularis was collected from 5 loca-
tions in the Lower Hudson Valley (Figure). Of the 123
pools tested, evidence of B. microti was found in 5 pools
of female ticks collected from 3 locations (Table). None of
the pools of New York nymphs was positive for B. microti.
The positive pools collected from Columbia and
Westchester Counties each contained 10 females, while the
single positive pool from Dutchess County contained 7
female ticks. 
To confirm the identity of each positive PCR product,
amplimers were sequenced by using primers Bab 1 and
Bab 4. Initial database (GenBank, EMBL, DDBJ) search-
es for each PCR positive sequence by using MacVector
7.1.1 (Accelrys, San Diego, CA, USA) software
(BLASTN, National Institutes of Health, Bethesda, MD,
USA) showed high homology with the B. microti strain GI
16S-like small subunit rRNA gene. For further confirma-
tion, the sequences were aligned and compared to the B.
microti 16S-like gene from strain GI reported by Persing et
al. (3). Homology between the documented 16S-like gene
sequence and all 5 PCR products was 100% (not shown).
A 60-bp sequence segment, representing all 5 positive
specimens, was deposited in GenBank (accession no.
AY724679).
Conclusions
Borrelia burgdorferi and Anaplasma phagocytophila,
the causative agents of Lyme disease and human granulo-
cytic ehrlichiosis, respectively, have been studied more
frequently in this region of New York than has B. microti.
With the discovery of a cluster of human babesiosis cases
in the Hudson Valley region, we focused on detecting B.
microti in vector populations. Finding B. microti in local
populations of I. scapularis provides evidence of locally
acquired human babesiosis in the Hudson Valley Region.
Since B. microti is maintained through the same reservoir
and vector species as the causative agent of Lyme disease
(5), human cases of babesiosis in areas of this state consid-
ered endemic for Lyme disease would not be unexpected.
The 5 cases represent the first reports of locally acquired
babesiosis in residents of New York not living in New York
City or on Long Island. 
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Figure. New York State Hudson Valley region. Circles denote gen-
eralized locations of tick collection sites in close proximity to local-
ly acquired human babesiosis cases. As passive and active surveillance of human disease
and tick distribution have demonstrated the continual
expansion of Lyme disease and I. scapularis throughout
New York (18), public health authorities should be aware
of the potential for an increase in the geographic range of
other human diseases transmitted by I. scapularis.
Accordingly, the New York State Department of Health
sent a letter alerting New York physicians to the possibili-
ty of patients’ acquiring babesiosis in the lower Hudson
Valley. Precautions to prevent tick bites should be adhered
to, especially as more information becomes available with
regard to the variety of pathogens being transmitted by a
single tick species. Further studies to determine the preva-
lence and distribution of B. microti–infected ticks, as well
as investigations of simultaneous infection by multiple
pathogens such as B. burgdorferi and A. phagocytophila,
are necessary to more readily define the expanding range
of I. scapularis and the disease agents it harbors.
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